Cargando…

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study

Concerns about bone health in transgender people using gender‐affirming hormonal treatment (HT) exist, but the fracture risk is not known. In this nationwide cohort study, we aimed to compare the fracture incidence in transgender people using long‐term HT with an age‐matched reference population. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiepjes, Chantal M, de Blok, Christel JM, Staphorsius, Annemieke S, Nota, Nienke M, Vlot, Mariska C, de Jongh, Renate T, den Heijer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003754/
https://www.ncbi.nlm.nih.gov/pubmed/31487065
http://dx.doi.org/10.1002/jbmr.3862
_version_ 1783494588468559872
author Wiepjes, Chantal M
de Blok, Christel JM
Staphorsius, Annemieke S
Nota, Nienke M
Vlot, Mariska C
de Jongh, Renate T
den Heijer, Martin
author_facet Wiepjes, Chantal M
de Blok, Christel JM
Staphorsius, Annemieke S
Nota, Nienke M
Vlot, Mariska C
de Jongh, Renate T
den Heijer, Martin
author_sort Wiepjes, Chantal M
collection PubMed
description Concerns about bone health in transgender people using gender‐affirming hormonal treatment (HT) exist, but the fracture risk is not known. In this nationwide cohort study, we aimed to compare the fracture incidence in transgender people using long‐term HT with an age‐matched reference population. All adult transgender people who started HT before 2016 at our gender‐identity clinic were included and were linked to a random population‐based sample of 5 age‐matched reference men and 5 age‐matched reference women per person. Fracture incidence was determined using diagnoses from visits to hospital emergency rooms nationwide between 2013 and 2015. A total of 1089 trans women aged <50 years (mean 38 ± 9 years) and 934 trans women aged ≥50 years (mean 60 ± 8 years) using HT for median 8 (interquartile range [IQR] 3–16) and 19 (IQR 11–29) years, respectively, were included. A total of 2.4% of the trans women aged <50 years had a fracture, whereas 3.0% of the age‐matched reference men (odds ratio [OR] = 0.78, 95% confidence interval [CI] 0.51–1.19) and 1.6% of the age‐matched reference women (OR = 1.49, 95% CI 0.96–2.32) experienced a fracture. In trans women aged ≥50 years, 4.4% experienced a fracture compared with 2.4% of the age‐matched reference men (OR = 1.90, 95% CI 1.32–2.74) and 4.2% of the age‐matched reference women (OR = 1.05, 95% CI 0.75–1.49). A total of 1036 trans men (40 ± 14 years) using HT for median 9 (IQR 2–22) years were included. Fractures occurred in 1.7% of the trans men, 3.0% of the age‐matched reference men (OR = 0.57, 95% CI 0.35–0.94), and 2.2% of the age‐matched reference women (OR = 0.79, 95% CI 0.48–1.30). In conclusion, fracture risk was higher in older trans women compared with age‐matched reference men. In young trans women, fracture risk tended to be increased compared with age‐matched reference women. Fracture risk was not increased in young trans men. © 2019 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.
format Online
Article
Text
id pubmed-7003754
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-70037542020-02-10 Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study Wiepjes, Chantal M de Blok, Christel JM Staphorsius, Annemieke S Nota, Nienke M Vlot, Mariska C de Jongh, Renate T den Heijer, Martin J Bone Miner Res Original Articles Concerns about bone health in transgender people using gender‐affirming hormonal treatment (HT) exist, but the fracture risk is not known. In this nationwide cohort study, we aimed to compare the fracture incidence in transgender people using long‐term HT with an age‐matched reference population. All adult transgender people who started HT before 2016 at our gender‐identity clinic were included and were linked to a random population‐based sample of 5 age‐matched reference men and 5 age‐matched reference women per person. Fracture incidence was determined using diagnoses from visits to hospital emergency rooms nationwide between 2013 and 2015. A total of 1089 trans women aged <50 years (mean 38 ± 9 years) and 934 trans women aged ≥50 years (mean 60 ± 8 years) using HT for median 8 (interquartile range [IQR] 3–16) and 19 (IQR 11–29) years, respectively, were included. A total of 2.4% of the trans women aged <50 years had a fracture, whereas 3.0% of the age‐matched reference men (odds ratio [OR] = 0.78, 95% confidence interval [CI] 0.51–1.19) and 1.6% of the age‐matched reference women (OR = 1.49, 95% CI 0.96–2.32) experienced a fracture. In trans women aged ≥50 years, 4.4% experienced a fracture compared with 2.4% of the age‐matched reference men (OR = 1.90, 95% CI 1.32–2.74) and 4.2% of the age‐matched reference women (OR = 1.05, 95% CI 0.75–1.49). A total of 1036 trans men (40 ± 14 years) using HT for median 9 (IQR 2–22) years were included. Fractures occurred in 1.7% of the trans men, 3.0% of the age‐matched reference men (OR = 0.57, 95% CI 0.35–0.94), and 2.2% of the age‐matched reference women (OR = 0.79, 95% CI 0.48–1.30). In conclusion, fracture risk was higher in older trans women compared with age‐matched reference men. In young trans women, fracture risk tended to be increased compared with age‐matched reference women. Fracture risk was not increased in young trans men. © 2019 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2019-10-07 2020-01 /pmc/articles/PMC7003754/ /pubmed/31487065 http://dx.doi.org/10.1002/jbmr.3862 Text en © 2019 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Wiepjes, Chantal M
de Blok, Christel JM
Staphorsius, Annemieke S
Nota, Nienke M
Vlot, Mariska C
de Jongh, Renate T
den Heijer, Martin
Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
title Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
title_full Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
title_fullStr Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
title_full_unstemmed Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
title_short Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
title_sort fracture risk in trans women and trans men using long‐term gender‐affirming hormonal treatment: a nationwide cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003754/
https://www.ncbi.nlm.nih.gov/pubmed/31487065
http://dx.doi.org/10.1002/jbmr.3862
work_keys_str_mv AT wiepjeschantalm fractureriskintranswomenandtransmenusinglongtermgenderaffirminghormonaltreatmentanationwidecohortstudy
AT deblokchristeljm fractureriskintranswomenandtransmenusinglongtermgenderaffirminghormonaltreatmentanationwidecohortstudy
AT staphorsiusannemiekes fractureriskintranswomenandtransmenusinglongtermgenderaffirminghormonaltreatmentanationwidecohortstudy
AT notanienkem fractureriskintranswomenandtransmenusinglongtermgenderaffirminghormonaltreatmentanationwidecohortstudy
AT vlotmariskac fractureriskintranswomenandtransmenusinglongtermgenderaffirminghormonaltreatmentanationwidecohortstudy
AT dejonghrenatet fractureriskintranswomenandtransmenusinglongtermgenderaffirminghormonaltreatmentanationwidecohortstudy
AT denheijermartin fractureriskintranswomenandtransmenusinglongtermgenderaffirminghormonaltreatmentanationwidecohortstudy